Contact this trialFirst, we need to learn more about you.
Anti-tumor antibiotic
BMN 349 for Alpha-1 Antitrypsin Deficiency
Recruiting0 awardsPhase 1
San Diego, California
This trial aims to test the safety of a single dose of BMN 349 in people with specific genetic mutations. They will be monitored for any negative effects, such as adverse events or abnormalities in lab
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service